{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:24:50Z","timestamp":1794029090855,"version":"4.8.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007797","name":"University of Helsinki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["350193"],"award-info":[{"award-number":["350193"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.neuropharm.2026.111217","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:50:19Z","timestamp":1791269419000},"page":"111217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effects of metabotropic 2\/3-glutamate receptor agonism and antagonism on activity-based anorexia model in mice"],"prefix":"10.1016","volume":"302","author":[{"given":"Tuomas","family":"Varjelus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4226-0905","authenticated-orcid":false,"given":"Atte","family":"Oksanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1771-3348","authenticated-orcid":false,"given":"Laura","family":"Kaljala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8201-817X","authenticated-orcid":false,"given":"Maria","family":"Ryazantseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9332-3340","authenticated-orcid":false,"given":"Teemu","family":"Aitta-aho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111217_bib1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41531-025-01138-1","article-title":"Targeting metabotropic glutamate receptors for symptomatic and disease-modifying treatment in Parkinson's disease","volume":"11","author":"Alborghetti","year":"2025","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.neuropharm.2026.111217_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2023.114349","article-title":"Timing matters: the contribution of running during different periods of the light\/dark cycle to susceptibility to activity-based anorexia in rats","volume":"271","author":"Aston","year":"2023","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2026.111217_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s40337-023-00941-6","article-title":"Atypical antipsychotic use does not impact weight gain for individuals with extreme anorexia nervosa: a retrospective case-control study","volume":"11","author":"Bauschka","year":"2023","journal-title":"J. Eat. Disord."},{"key":"10.1016\/j.neuropharm.2026.111217_bib4","first-page":"829","article-title":"Vulnerable and resilient phenotypes in a mouse model of anorexia nervosa","volume":"90","author":"Beeler","year":"2021","journal-title":"Biol. Psychiat. Corticost. Funct. Eating Disord."},{"key":"10.1016\/j.neuropharm.2026.111217_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00208","article-title":"Metabotropic Glutamate2 receptors play a key role in modulating head twitches induced by a serotonergic hallucinogen in mice","volume":"9","author":"Benvenga","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111217_bib6","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1124\/jpet.106.110684","article-title":"Habituation deficits induced by metabotropic glutamate receptors 2\/3 receptor blockade in mice: reversal by antipsychotic drugs","volume":"320","author":"Bespalov","year":"2007","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.111217_bib7","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/npp.2015.314","article-title":"Evidence for thalamocortical circuit abnormalities and associated cognitive dysfunctions in underweight individuals with anorexia nervosa","volume":"41","author":"Biezonski","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111217_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/archpsyc.63.3.305","article-title":"Prevalence, heritability, and prospective risk factors for anorexia nervosa","volume":"63","author":"Bulik","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111217_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1583672","article-title":"Gender differences in eating disorders","volume":"12","author":"Capuano","year":"2025","journal-title":"Front. Nutr."},{"key":"10.1016\/j.neuropharm.2026.111217_bib10","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jpsychires.2006.09.013","article-title":"Adolescent anorexia nervosa: cross-sectional and follow-up frontal gray matter disturbances detected with proton magnetic resonance spectroscopy","volume":"41","author":"Castro-Fornieles","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2026.111217_bib11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/bs.apha.2020.04.001","article-title":"mGlu2\/3 receptor as a novel target for rapid acting antidepressants","volume":"89","author":"Chaki","year":"2020","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111217_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuropharm.2012.05.022","article-title":"mGlu2\/3 and mGlu5 receptors: potential targets for novel antidepressants","volume":"66","author":"Chaki","year":"2013","journal-title":"Neuropharmacol. Metabot. Glutamat. Recept."},{"key":"10.1016\/j.neuropharm.2026.111217_bib14","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s00429-016-1341-7","article-title":"NR2A- and NR2B-NMDA receptors and drebrin within postsynaptic spines of the hippocampus correlate with hunger-evoked exercise","volume":"222","author":"Chen","year":"2017","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuropharm.2026.111217_bib13","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1523\/JNEUROSCI.21-11-03705.2001","article-title":"Time-dependent reversal of long-term potentiation by low-frequency stimulation at the hippocampal mossy fiber-CA3 synapses","volume":"21","author":"Chen","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111217_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108687","article-title":"Targeting metabotropic glutamate receptors for the treatment of depression and other stress-related disorders","volume":"196","author":"Dogra","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111217_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1124\/molpharm.121.000460","article-title":"Metabotropic glutamate receptors as emerging targets for the treatment of schizophrenia","volume":"101","author":"Dogra","year":"2022","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111217_bib17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.biopsych.2021.02.970","article-title":"Activating mGlu3 metabotropic glutamate receptors rescues schizophrenia-like cognitive deficits through metaplastic adaptations within the hippocampus","volume":"90","author":"Dogra","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111217_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/syn.70005","article-title":"Subanesthetic ketamine ameliorates activity-based anorexia of adult mice","volume":"79","author":"Dong","year":"2025","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2026.111217_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2025.114956","article-title":"Mechanisms underlying sustained resilience against anorexia nervosa from sub-anesthetic ketamine: a review and new research based on electron microscopic analyses of synapses using a mouse model","volume":"298","author":"Dong","year":"2025","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2026.111217_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/hipo.70039","article-title":"Ketamine sustains and enhances the protective effects of a ketogenic diet against relapses in an anorexia mouse model","volume":"35","author":"Dong","year":"2025","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2026.111217_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.coph.2018.02.004","article-title":"Metabotropic glutamate receptors as targets for novel anxiolytics","volume":"38","author":"Ferraguti","year":"2018","journal-title":"Curr. Opin. Pharmacol. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111217_bib22","first-page":"330","article-title":"Taking better advantage of the activity-based anorexia model","volume":"30","author":"Foldi","year":"2024","journal-title":"Trend Molecul. Med. Special issue: Eat. Disord."},{"key":"10.1016\/j.neuropharm.2026.111217_bib23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00213-016-4477-5","article-title":"Brain glutamate in anorexia nervosa: a magnetic resonance spectroscopy case control study at 7 Tesla","volume":"234","author":"Godlewska","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.111217_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2498","article-title":"Effectiveness of olanzapine in the treatment of anorexia nervosa: a systematic review and meta\u2010analysis","volume":"12","author":"Han","year":"2022","journal-title":"Brain Behav"},{"key":"10.1016\/j.neuropharm.2026.111217_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/npp.2016.199","article-title":"Inflammation, glutamate, and glia: a trio of trouble in mood disorders","volume":"42","author":"Haroon","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111217_bib26","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/pgmj.71.842.712","article-title":"Anorexia nervosa--diagnosis, aetiology, and treatment","volume":"71","author":"Hartman","year":"1995","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.neuropharm.2026.111217_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.109921","article-title":"Anorexia nervosa, zinc deficiency and the glutamate system: the ketamine option","volume":"101","author":"Hermens","year":"2020","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111217_bib28","article-title":"Atypical antipsychotics use in eating disorders. Review","volume":"vol. 33","author":"Hern\u00e1ndez S\u00e1nchez","year":"2016"},{"key":"10.1016\/j.neuropharm.2026.111217_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-008-1236-2","article-title":"Individual contribution of metabotropic glutamate receptor (mGlu) 2 and 3 to c-Fos expression pattern evoked by mGlu2\/3 antagonism","volume":"201","author":"Hetzenauer","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111217_bib30","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1460-9568.2009.07004.x","article-title":"Extinction of cued fear memory involves a distinct form of depotentiation at cortical input synapses onto the lateral amygdala","volume":"30","author":"Hong","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111217_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/157015912799362805","article-title":"Therapeutic potential of metabotropic glutamate receptor modulators","volume":"10","author":"Hovels\u00f8","year":"2012","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2026.111217_bib32","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/eat.23752","article-title":"Adolescent female rats recovered from the activity\u2010based anorexia display blunted hedonic responding","volume":"55","author":"Hurley","year":"2022","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.neuropharm.2026.111217_bib33","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1527-3458.2007.00024.x","article-title":"The preclinical Properties of a Novel Group II metabotropic glutamate receptor agonist LY379268","volume":"13","author":"Imre","year":"2007","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.neuropharm.2026.111217_bib34","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuron.2019.09.044","article-title":"mGlu2 and mGlu3 negative allosteric modulators divergently potentiate thalamocortical transmission and exert rapid antidepressant-like effects","volume":"105","author":"Joffe","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111217_bib35","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/erv.3039","article-title":"Novel treatments for anorexia nervosa: insights from neuroplasticity research","volume":"32","author":"Keeler","year":"2024","journal-title":"Eur. Eat. Disord. Rev."},{"key":"10.1016\/j.neuropharm.2026.111217_bib36","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/978-1-61779-458-2_25","article-title":"The activity-based anorexia mouse model","volume":"829","author":"Klenotich","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuropharm.2026.111217_bib37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00429-023-02740-w","article-title":"Ketamine ameliorates activity-based anorexia of adolescent female mice through changes in GluN2B-containing NMDA receptors at postsynaptic cytoplasmic locations of pyramidal neurons and interneurons of medial prefrontal cortex","volume":"229","author":"Li","year":"2024","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuropharm.2026.111217_bib38","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neuropharm.2009.05.002","article-title":"Use of MGLUR2 and MGLUR3 knockout mice to explore in vivo receptor specificity of the MGLUR2\/3 selective antagonist LY341495","volume":"57","author":"Linden","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111217_bib39","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00213-004-2098-x","article-title":"Anxiolytic-like activity of the mGLU2\/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice","volume":"179","author":"Linden","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.111217_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13041-017-0293-z","article-title":"Targeting metabotropic glutamate receptors for novel treatments of schizophrenia","volume":"10","author":"Maksymetz","year":"2017","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuropharm.2026.111217_bib41","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.coph.2018.03.004","article-title":"Metabotropic glutamate receptors: targets for neuroprotective therapies in Parkinson disease","volume":"38","author":"Masilamoni","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111217_bib42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.gep.2016.10.001","article-title":"Developmental expression of mGlu2 and mGlu3 in the mouse brain","volume":"22","author":"McOmish","year":"2016","journal-title":"Gene Expr. Patterns"},{"key":"10.1016\/j.neuropharm.2026.111217_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002646","article-title":"The incidence of eating disorders in the UK in 2000\u20132009: findings from the General Practice Research Database","volume":"3","author":"Micali","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.neuropharm.2026.111217_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105279","article-title":"Excitatory and inhibitory neurometabolites in anorexia nervosa: a systematic review of proton magnetic resonance spectroscopy studies","volume":"152","author":"Mitchell","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2026.111217_bib45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40263-022-00984-4","article-title":"Ketamine and zinc: treatment of anorexia nervosa via dual NMDA receptor modulation","volume":"37","author":"Mitchell","year":"2023","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2026.111217_bib46","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.3390\/nu12123661","article-title":"Activity-based anorexia dynamically dysregulates the glutamatergic synapse in the nucleus accumbens of female adolescent rats","volume":"12","author":"Mottarlini","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.neuropharm.2026.111217_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2022.1087075","article-title":"Long-lasting BDNF signaling alterations in the amygdala of adolescent female rats exposed to the activity-based anorexia model","volume":"16","author":"Mottarlini","year":"2022","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111217_bib48","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/jnc.15605","article-title":"Cortical reorganization of the glutamate synapse in the activity-based anorexia rat model: impact on cognition","volume":"161","author":"Mottarlini","year":"2022","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.111217_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111065","article-title":"Developmental activity-based anorexia alters hippocampal non-genomic stress response and induces structural instability and spatial memory impairment in female rats","volume":"134","author":"Mottarlini","year":"2024","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111217_bib51","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0028-3908(03)00232-6","article-title":"Group II metabotropic glutamate receptor antagonists LY341495 and LY366457 increase locomotor activity in mice","volume":"45","author":"O'Neill","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111217_bib50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0896-6273(94)90459-6","article-title":"Immunohistochemical localization of metabotropic glutamate receptors, mGluR2 and mGluR3, in rat cerebellar cortex","volume":"13","author":"Ohishi","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111217_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2023.173531","article-title":"Role of group II metabotropic glutamate receptors in ketamine's antidepressant actions","volume":"223","author":"Onisiforou","year":"2023","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2026.111217_bib53","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1007\/s00213-016-4325-7","article-title":"Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats","volume":"233","author":"Podkowa","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.111217_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2019.12.011","article-title":"Antidepressant effects and mechanisms of group II mGlu receptor-specific negative allosteric modulators","volume":"105","author":"Potter","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111217_bib55","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/glia.24579","article-title":"Astrocytic PAR1 and mGluR2\/3 control synaptic glutamate time course at hippocampal CA1 synapses","volume":"72","author":"Roh","year":"2024","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2026.111217_bib56","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1523\/JNEUROSCI.1519-16.2016","article-title":"Activation of group II metabotropic glutamate receptors promotes LTP induction at schaffer Collateral-CA1 pyramidal cell synapses by priming NMDA receptors","volume":"36","author":"Rosenberg","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111217_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2019.00069","article-title":"Activity based anorexia as an animal model for anorexia Nervosa\u2013A systematic review","volume":"6","author":"Schalla","year":"2019","journal-title":"Front. Nutr."},{"key":"10.1016\/j.neuropharm.2026.111217_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.nsa.2024.104055","article-title":"Neuronal activation in the paraventricular thalamus and lateral habenula during activity-based anorexia in mice","volume":"3","author":"Sch\u00e9le","year":"2024","journal-title":"Neurosci. Appl."},{"key":"10.1016\/j.neuropharm.2026.111217_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2024.173826","article-title":"mGlu2\/3 receptor agonist (LY354740) in anxiety","volume":"242","author":"Schoepp","year":"2024","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2026.111217_bib60","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.neuropharm.2006.10.003","article-title":"The effects of the mGluR5 antagonist MPEP and the mGluR2\/3 antagonist LY341495 on rats' performance in the 5-choice serial reaction time task","volume":"52","author":"Semenova","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111217_bib61","first-page":"287","article-title":"Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression","volume":"34","author":"Sos","year":"2013","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.neuropharm.2026.111217_bib62","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jad.2023.12.035","article-title":"Examining anxious temperament in anorexia nervosa: behavioural inhibition and intolerance of uncertainty and their contribution to trait anxiety in adolescents with anorexia nervosa","volume":"348","author":"Sternheim","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2026.111217_bib63","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0024-3205(03)00509-5","article-title":"Antipsychotic action of selective group II metabotropic glutamate receptor agonist MGS0008 and MGS0028 on conditioned avoidance responses in the rat","volume":"73","author":"Takamori","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2026.111217_bib64","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0925-4927(01)00093-2","article-title":"Abnormal neuronal network in anorexia nervosa studied with I-123-IMP SPECT","volume":"107","author":"Takano","year":"2001","journal-title":"Psychiatr. Res. Neuroimaging"},{"key":"10.1016\/j.neuropharm.2026.111217_bib65","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1523\/JNEUROSCI.14-05-03005.1994","article-title":"Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat","volume":"14","author":"Testa","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111217_bib66","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/eat.23004","article-title":"Psychiatric and medical correlates of DSM-5 eating disorders in a nationally representative sample of adults in the United States","volume":"52","author":"Udo","year":"2019","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.neuropharm.2026.111217_bib67","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neuroimage.2006.12.009","article-title":"Motor- and food-related metabolic cerebral changes in the activity-based rat model for anorexia nervosa: a voxel-based microPET study","volume":"35","author":"van Kuyck","year":"2007","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2026.111217_bib68","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1001\/jama.295.22.2605","article-title":"Fluoxetine after weight restoration in anorexia NervosaA randomized controlled trial","volume":"295","author":"Walsh","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2026.111217_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2022.849937","article-title":"Glutamate metabotropic receptor type 3 (mGlu3) localization in the rat prelimbic medial prefrontal cortex","volume":"16","author":"Woo","year":"2022","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.neuropharm.2026.111217_bib70","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00213-007-0974-x","article-title":"The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2\/3 agonist, LY379268, in mouse models predictive of antipsychotic activity","volume":"196","author":"Woolley","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.111217_bib71","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuropharm.2012.01.019","article-title":"CNS distribution of metabotropic glutamate 2 and 3 receptors: transgenic mice and [3H]LY459477 autoradiography","volume":"66","author":"Wright","year":"2013","journal-title":"Neuropharmacol. Metabot. Glutamat. Recept."},{"key":"10.1016\/j.neuropharm.2026.111217_bib72","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1073\/pnas.1819540116","article-title":"(2R,6R)-hydroxynorketamine exerts mGlu2 receptor-dependent antidepressant actions","volume":"116","author":"Zanos","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2026.111217_bib73","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/RLU.0000000000000261","article-title":"Metabolic imaging of deep brain stimulation in anorexia nervosa: a 18F-FDG PET\/CT study","volume":"38","author":"Zhang","year":"2013","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.neuropharm.2026.111217_bib74","article-title":"The utility of animal models for studying the Metabo-Psychiatric origins of Anorexia nervosa","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Psychiatr."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:51:09Z","timestamp":1794027069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826003928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":74,"alternative-id":["S0028390826003928"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111217","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of metabotropic 2\/3-glutamate receptor agonism and antagonism on activity-based anorexia model in mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111217"}}